World's Best Scientists 2026 revealed!

D-Index & Metrics

Psychology

D-Index
66
Citations
27773
World Ranking
2648
National Ranking
17

Mark Weiser publication distribution in Psychology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Psychology in 2026. The highlighted bar marks where Mark Weiser sits on this spectrum.

31–40 publications: 6 scientists 41–50 publications: 52 scientists 51–60 publications: 138 scientists 61–70 publications: 299 scientists 71–80 publications: 461 scientists 81–90 publications: 605 scientists 91–100 publications: 713 scientists 101–110 publications: 736 scientists 111–120 publications: 686 scientists 121–130 publications: 670 scientists 131–140 publications: 644 scientists 141–150 publications: 597 scientists 151–160 publications: 576 scientists 161–170 publications: 477 scientists 171–180 publications: 450 scientists 181–190 publications: 397 scientists 191–200 publications: 343 scientists 201–210 publications: 328 scientists 211–220 publications: 313 scientists 221–230 publications: 283 scientists 231–240 publications: 226 scientists 241–250 publications: 196 scientists 251–260 publications: 201 scientists 261–270 publications: 171 scientists 271–280 publications: 151 scientists 281–290 publications: 139 scientists 291–300 publications: 113 scientists 301–310 publications: 102 scientists 311–320 publications: 100 scientists 321–330 publications: 76 scientists 331–340 publications: 92 scientists 341–350 publications: 85 scientists 351–360 publications: 69 scientists 361–370 publications: 71 scientists 371–380 publications: 63 scientists 381–390 publications: 58 scientists 391–400 publications: 57 scientists 401–410 publications: 43 scientists 411–420 publications: 33 scientists 421–430 publications: 50 scientists 431–440 publications: 41 scientists 441–450 publications: 32 scientists 451–460 publications: 27 scientists 461–470 publications: 28 scientists 471–480 publications: 25 scientists 481–490 publications: 28 scientists 491–500 publications: 20 scientists 501–510 publications: 23 scientists 511–520 publications: 26 scientists 521–530 publications: 17 scientists 531–540 publications: 21 scientists 541–550 publications: 14 scientists 551–560 publications: 16 scientists 561–570 publications: 10 scientists 571–580 publications: 22 scientists 581–590 publications: 9 scientists 591–600 publications: 14 scientists 601–610 publications: 9 scientists 611–620 publications: 11 scientists 621–630 publications: 4 scientists 631–640 publications: 7 scientists 641–650 publications: 5 scientists 651–660 publications: 10 scientists 661–670 publications: 8 scientists 671–680 publications: 8 scientists 681–690 publications: 4 scientists 691–700 publications: 3 scientists 701–704 publications: 4 scientists 705+ publications: 100 scientists
31 publications 705+

This scientist: 272 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 705 publications or more.

Mark Weiser D-index placement in Psychology in 2026

The chart shows the D-index (discipline H-index) distribution of Psychology scientists ranked by Research.com in 2026. The highlighted bar marks where Mark Weiser sits on this spectrum.

30–31 D-Index: 398 scientists 32–33 D-Index: 702 scientists 34–35 D-Index: 671 scientists 36–37 D-Index: 659 scientists 38–39 D-Index: 641 scientists 40–41 D-Index: 671 scientists 42–43 D-Index: 617 scientists 44–45 D-Index: 558 scientists 46–47 D-Index: 495 scientists 48–49 D-Index: 487 scientists 50–51 D-Index: 445 scientists 52–53 D-Index: 390 scientists 54–55 D-Index: 408 scientists 56–57 D-Index: 345 scientists 58–59 D-Index: 325 scientists 60–61 D-Index: 321 scientists 62–63 D-Index: 248 scientists 64–65 D-Index: 290 scientists 66–67 D-Index: 218 scientists 68–69 D-Index: 219 scientists 70–71 D-Index: 215 scientists 72–73 D-Index: 183 scientists 74–75 D-Index: 169 scientists 76–77 D-Index: 132 scientists 78–79 D-Index: 137 scientists 80–81 D-Index: 120 scientists 82–83 D-Index: 112 scientists 84–85 D-Index: 86 scientists 86–87 D-Index: 101 scientists 88–89 D-Index: 83 scientists 90–91 D-Index: 77 scientists 92–93 D-Index: 70 scientists 94–95 D-Index: 78 scientists 96–97 D-Index: 58 scientists 98–99 D-Index: 53 scientists 100–101 D-Index: 57 scientists 102–103 D-Index: 48 scientists 104–105 D-Index: 53 scientists 106–107 D-Index: 46 scientists 108–109 D-Index: 24 scientists 110–111 D-Index: 35 scientists 112–113 D-Index: 27 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 31 scientists 118–119 D-Index: 22 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 24 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 11 scientists 128–129 D-Index: 19 scientists 130–131 D-Index: 10 scientists 132–133 D-Index: 16 scientists 134–135 D-Index: 10 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 5 scientists 142–143 D-Index: 12 scientists 144+ D-Index: 98 scientists
30 D-Index 144+

This scientist: 66 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 144 D-Index or more.

Overview

Mark Weiser is affiliated with Sheba Medical Center in Israel and has conducted extensive research primarily within the fields of Medicine and Psychology. Their work focuses largely on Psychiatry and Mental Health, with significant contributions to areas such as Cognitive Neuroscience, Clinical Psychology, Experimental and Cognitive Psychology, and Social Psychology.

The scientist's research topics cover a variety of mental health and neuroscience-related areas. Key topics include:

  • Schizophrenia research and treatment
  • Functional Brain Connectivity Studies
  • Bipolar Disorder and Treatment
  • Mental Health Treatment and Access
  • Mental Health Research Topics
  • Treatment of Major Depression
  • Advanced Neuroimaging Techniques and Applications

Mark Weiser has published multiple papers in frequent and reputable venues such as:

  • Schizophrenia Bulletin
  • Schizophrenia Research
  • The Lancet Psychiatry
  • European Neuropsychopharmacology
  • Psychological Medicine

Recent notable publications by the scientist include:

  • Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia (2022) published in Schizophrenia Bulletin
  • Traumatic Brain Injury Severity in a Network Perspective: A Diffusion MRI Based Connectome Study (2020) published in Scientific Reports
  • Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST) (2023) published in The Lancet Psychiatry
  • Adjunctive Aspirin vs Placebo in Patients With Schizophrenia: Results of Two Randomized Controlled Trials (2020) published in Schizophrenia Bulletin
  • COVID-19 and severe mental illness in Israel: testing, infection, hospitalization, mortality and vaccination rates in a countrywide study (2022) published in Molecular Psychiatry

Collaborative efforts have involved frequent co-authors, including:

  • Linda Levi
  • René S. Kahn
  • John M. Davis
  • Michael Davidson
  • Inge Winter-van Rossum

Best Publications

  • Biological insights from 108 schizophrenia-associated genetic loci

    Stephan Ripke;Stephan Ripke;Benjamin M. Neale;Benjamin M. Neale;Aiden Corvin;James T. R. Walters

  • Analysis of shared heritability in common disorders of the brain

    Verneri Anttila;Verneri Anttila;Brendan Bulik-Sullivan;Brendan Bulik-Sullivan;Hilary K. Finucane;Raymond K. Walters;Raymond K. Walters

  • Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores

    Bjarni J. Vilhjálmsson;Jian Yang;Hilary K. Finucane;Alexander Gusev

  • Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders

    Phil H. Lee;Verneri Anttila;Hyejung Won;Yen-Chen A. Feng

  • Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects

    Christian R Marshall;Daniel P Howrigan;Daniel P Howrigan;Daniele Merico;Bhooma Thiruvahindrapuram

  • Advancing Paternal Age and Autism

    Abraham Reichenberg;Raz Gross;Mark Weiser;Michealine Bresnahan

  • Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents.

    Michael Davidson;Abraham Reichenberg;Jonathan Rabinowitz;Mark Weiser

  • Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes

    Douglas M. Ruderfer;Stephan Ripke;Stephan Ripke;Stephan Ripke;Andrew McQuillin;James Boocock

  • Do subthreshold psychotic experiences predict clinical outcomes in unselected non-help-seeking population-based samples? A systematic review and meta-analysis, enriched with new results

    N. Kaymaz;M. Drukker;Roselind Lieb;Hans-Ulrich Wittchen

  • A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder.

    Abraham Reichenberg;Mark Weiser;Jonathan Rabinowitz;Asaf Caspi

  • Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST)

    Michael Davidson;Silvana Galderisi;Mark Weiser;Nomi Werbeloff

  • Family history of schizophrenia and bipolar disorder as risk factors for autism.

    Patrick F. Sullivan;Cecilia Magnusson;Abraham Reichenberg;Marcus Boman

  • Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode.

    Asaf Caspi;Abraham Reichenberg;Mark Weiser;Jonathan Rabinowitz

  • Strong synaptic transmission impact by copy number variations in schizophrenia

    Joseph T. Glessner;Muredach P. Reilly;Cecilia E. Kim;Nagahide Takahashi

  • Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials.

    Masahiro Nitta;Taishiro Kishimoto;Norbert Müller;Mark Weiser

  • Self-reported attenuated psychotic symptoms as forerunners of severe mental disorders later in life.

    Nomi Werbeloff;Marjan Drukker;Bruce P. Dohrenwend;Itzhak Levav

  • Higher Rates of Cigarette Smoking in Male Adolescents Before the Onset of Schizophrenia: A Historical-Prospective Cohort Study

    Mark Weiser;Abraham Reichenberg;Itamar Grotto;Ross Yasvitzky

  • Elaboration on Premorbid Intellectual Performance in Schizophrenia Premorbid Intellectual Decline and Risk for Schizophrenia

    Abraham Reichenberg;Mark Weiser;Michael A. Rapp;Jonathan Rabinowitz

  • Paternal age and intelligence: implications for age-related genomic changes in male germ cells.

    Dolores Malaspina;Avi Reichenberg;Mark Weiser;Shmuel Fennig

  • Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study.

    René S Kahn;Inge Winter van Rossum;Stefan Leucht;Philip McGuire;Philip McGuire

  • Genome wide meta-analysis identifies genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders

    Lee Ph;Anttila;Won H

Frequent Co-Authors

Michael H. Davidson
Michael H. Davidson University of Chicago
Abraham Reichenberg
Abraham Reichenberg Icahn School of Medicine at Mount Sinai
Jim van Os
Jim van Os University Medical Center Utrecht
Tune H. Pers
Tune H. Pers University of Copenhagen
Danielle Posthuma
Danielle Posthuma Vrije Universiteit Amsterdam
Aarno Palotie
Aarno Palotie University of Helsinki
Jeremy M. Silverman
Jeremy M. Silverman Icahn School of Medicine at Mount Sinai
Thomas Werge
Thomas Werge University of Copenhagen
Vahram Haroutunian
Vahram Haroutunian Icahn School of Medicine at Mount Sinai
Stephan Ripke
Stephan Ripke Massachusetts General Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're exploring Psychology as a field of study, it's important to consider program value and career outcomes—especially with so many online options now available. Choosing one of the most valuable psychology degree programs ranking in America can make a significant difference in your future career prospects and return on investment.

You'll find a range of specializations available, from counseling and clinical psychology to forensic and industrial-organizational tracks. Some regions offer unique advantages—consider the most valuable psychology degrees in St. Louis and the most valuable psychology degrees in Tampa for programs that emphasize high employment rates and hands-on learning. Similarly, students looking for affordability and outcomes should explore the best value psychology degrees in South Carolina.

Graduates can pursue roles in mental health services, human resources, or research. As the demand for psychological expertise grows, choosing the right online degree can open doors to diverse pathways in healthcare, education, business, and beyond.

Best Scientists Citing Mark Weiser

Trending Scientists

Recently Published Articles